As MYC is frequently amplified or overexpressed in high-grade breast tumors25,31, substantial efforts have been put forth to target MYC, either directly21–23 or by exploiting MYC-induced cancer vulnerabilities21,24,25. The gene discussed is MYC; the disease is cancer.